117 related articles for article (PubMed ID: 36718661)
41. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
[TBL] [Abstract][Full Text] [Related]
42. Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α signaling pathway.
Wei J; Wu J; Xu W; Nie H; Zhou R; Wang R; Liu Y; Tang G; Wu J
Cell Death Dis; 2018 May; 9(6):599. PubMed ID: 29789538
[TBL] [Abstract][Full Text] [Related]
43. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
[TBL] [Abstract][Full Text] [Related]
44. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
46. FBXW7 modulates malignant potential and cisplatin-induced apoptosis in cholangiocarcinoma through NOTCH1 and MCL1.
Mori A; Masuda K; Ohtsuka H; Shijo M; Ariake K; Fukase K; Sakata N; Mizuma M; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Fujishima F; Unno M
Cancer Sci; 2018 Dec; 109(12):3883-3895. PubMed ID: 30302867
[TBL] [Abstract][Full Text] [Related]
47. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
Wu F; Gao P; Wu W; Wang Z; Yang J; Di J; Jiang B; Su X
J Exp Clin Cancer Res; 2018 Jul; 37(1):144. PubMed ID: 29996891
[TBL] [Abstract][Full Text] [Related]
48. PDIA6 contributes to aerobic glycolysis and cancer progression in oral squamous cell carcinoma.
Mao L; Wu X; Gong Z; Yu M; Huang Z
World J Surg Oncol; 2021 Mar; 19(1):88. PubMed ID: 33761940
[TBL] [Abstract][Full Text] [Related]
49. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
[TBL] [Abstract][Full Text] [Related]
50. Circ-PKD2 promotes Atg13-mediated autophagy by inhibiting miR-646 to increase the sensitivity of cisplatin in oral squamous cell carcinomas.
Gao L; Zhang Q; Li S; Zheng J; Ren W; Zhi K
Cell Death Dis; 2022 Feb; 13(2):192. PubMed ID: 35220397
[TBL] [Abstract][Full Text] [Related]
51. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Harada K; Ferdous T; Harada T; Ueyama Y
Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
[TBL] [Abstract][Full Text] [Related]
52. MiR-223 promotes oral squamous cell carcinoma proliferation and migration by regulating FBXW7.
Jiang L; Lv L; Liu X; Jiang X; Yin Q; Hao Y; Xiao L
Cancer Biomark; 2019; 24(3):325-334. PubMed ID: 30883339
[TBL] [Abstract][Full Text] [Related]
53. FBXW7 loss of function promotes esophageal squamous cell carcinoma progression via elevating MAP4 and ERK phosphorylation.
Pan Y; Liu J; Gao Y; Guo Y; Wang C; Liang Z; Wu M; Qian Y; Li Y; Shen J; Lu C; Ma S
J Exp Clin Cancer Res; 2023 Mar; 42(1):75. PubMed ID: 36991467
[TBL] [Abstract][Full Text] [Related]
54. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma.
Lu X; Wang Z; Huang H; Wang H
J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620
[TBL] [Abstract][Full Text] [Related]
55. METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance.
Qiao X; Zhu L; Song R; Shang C; Guo Y
Oral Dis; 2023 Apr; 29(3):942-956. PubMed ID: 34807506
[TBL] [Abstract][Full Text] [Related]
56. FTY720 increases paclitaxel efficacy in cisplatin-resistant oral squamous cell carcinoma.
Torres LAT; Silva G; Alves JSF; Ushida TR; Potenza J; Garcia CB; Sousa LO; Lopes NP; Almeida LO; Leopoldino AM
J Oral Pathol Med; 2024 Jan; 53(1):42-52. PubMed ID: 37946676
[TBL] [Abstract][Full Text] [Related]
57. The endothelial nitric oxide synthase/cyclic guanosine monophosphate/protein kinase G pathway activates primordial follicles.
Zhao P; Song Z; Wang Y; Cai H; Du X; Li C; Lv J; Liu X; Guo M; Chen Z
Aging (Albany NY); 2020 Dec; 13(1):1096-1119. PubMed ID: 33291075
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
59. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G
Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397
[TBL] [Abstract][Full Text] [Related]
60. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
Koo J; Wu X; Mao Z; Khuri FR; Sun SY
J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
